396 related articles for article (PubMed ID: 29246230)
1. Bifunctional enzyme ATIC promotes propagation of hepatocellular carcinoma by regulating AMPK-mTOR-S6 K1 signaling.
Li M; Jin C; Xu M; Zhou L; Li D; Yin Y
Cell Commun Signal; 2017 Dec; 15(1):52. PubMed ID: 29246230
[TBL] [Abstract][Full Text] [Related]
2. ATIC inhibits autophagy in hepatocellular cancer through the AKT/FOXO3 pathway and serves as a prognostic signature for modeling patient survival.
Zhang H; Xia P; Liu J; Chen Z; Ma W; Yuan Y
Int J Biol Sci; 2021; 17(15):4442-4458. PubMed ID: 34803509
[No Abstract] [Full Text] [Related]
3. Identification of ATIC as a Novel Target for Chemoradiosensitization.
Liu X; Paila UD; Teraoka SN; Wright JA; Huang X; Quinlan AR; Gatti RA; Concannon P
Int J Radiat Oncol Biol Phys; 2018 Jan; 100(1):162-173. PubMed ID: 29029884
[TBL] [Abstract][Full Text] [Related]
4. High-glucose toxicity is mediated by AICAR-transformylase/IMP cyclohydrolase and mitigated by AMP-activated protein kinase in
Riedinger C; Mendler M; Schlotterer A; Fleming T; Okun J; Hammes HP; Herzig S; Nawroth PP
J Biol Chem; 2018 Mar; 293(13):4845-4859. PubMed ID: 29414769
[TBL] [Abstract][Full Text] [Related]
5. SOX18 Affects Cell Viability, Migration, Invasiveness, and Apoptosis in Hepatocellular Carcinoma (HCC) Cells by Participating in Epithelial-to-Mesenchymal Transition (EMT) Progression and Adenosine Monophosphate Activated Protein Kinase (AMPK)/Mammalian Target of Rapamycin (mTOR).
Sun Y; Lei B; Huang Q
Med Sci Monit; 2019 Aug; 25():6244-6254. PubMed ID: 31427562
[TBL] [Abstract][Full Text] [Related]
6. Structural analyses of a purine biosynthetic enzyme from Mycobacterium tuberculosis reveal a novel bound nucleotide.
Le Nours J; Bulloch EM; Zhang Z; Greenwood DR; Middleditch MJ; Dickson JM; Baker EN
J Biol Chem; 2011 Nov; 286(47):40706-16. PubMed ID: 21956117
[TBL] [Abstract][Full Text] [Related]
7. The last enzyme of the de novo purine synthesis pathway 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase (ATIC) plays a central role in insulin signaling and the Golgi/endosomes protein network.
Boutchueng-Djidjou M; Collard-Simard G; Fortier S; Hébert SS; Kelly I; Landry CR; Faure RL
Mol Cell Proteomics; 2015 Apr; 14(4):1079-92. PubMed ID: 25687571
[TBL] [Abstract][Full Text] [Related]
8. Golgi phosphoprotein 3 (GOLPH3) promotes hepatocellular carcinoma progression by activating mTOR signaling pathway.
Liu H; Wang X; Feng B; Tang L; Li W; Zheng X; Liu Y; Peng Y; Zheng G; He Q
BMC Cancer; 2018 Jun; 18(1):661. PubMed ID: 29914442
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-145-5p suppresses cell proliferation, migration, and invasion in upper tract urothelial carcinoma by targeting 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase.
Luo HL; Lee YC; Chang YL; Hsu WC; Wu YT; Jhan JH; Lin HH; Wu YR; Ke HL; Liu HY
J Cell Biochem; 2023 Sep; 124(9):1324-1345. PubMed ID: 37475541
[TBL] [Abstract][Full Text] [Related]
10. Characterization of AICAR transformylase/IMP cyclohydrolase (ATIC) from Staphylococcus lugdunensis.
Verma P; Kar B; Varshney R; Roy P; Sharma AK
FEBS J; 2017 Dec; 284(24):4233-4261. PubMed ID: 29063699
[TBL] [Abstract][Full Text] [Related]
11. Alkaline ceramidase 3 promotes growth of hepatocellular carcinoma cells via regulating S1P/S1PR2/PI3K/AKT signaling.
Yin Y; Xu M; Gao J; Li M
Pathol Res Pract; 2018 Sep; 214(9):1381-1387. PubMed ID: 30097213
[TBL] [Abstract][Full Text] [Related]
12. AMPK Activation via Modulation of De Novo Purine Biosynthesis with an Inhibitor of ATIC Homodimerization.
Asby DJ; Cuda F; Beyaert M; Houghton FD; Cagampang FR; Tavassoli A
Chem Biol; 2015 Jul; 22(7):838-48. PubMed ID: 26144885
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of ATIC in multiple myeloma tissues based on tissue microarray and gene microarrays.
Li R; Chen G; Dang Y; He R; Liu A; Ma J; Wang C
Int J Lab Hematol; 2021 Jun; 43(3):409-417. PubMed ID: 33226193
[TBL] [Abstract][Full Text] [Related]
14. AICA-ribosiduria due to ATIC deficiency: Delineation of the phenotype with three novel cases, and long-term update on the first case.
Ramond F; Rio M; Héron B; Imbard A; Marie S; Billiemaz K; Denommé-Pichon AS; Kuentz P; Ceballos I; Piraud M; Vincent MF; Touraine R
J Inherit Metab Dis; 2020 Nov; 43(6):1254-1264. PubMed ID: 32557644
[TBL] [Abstract][Full Text] [Related]
15. The enzymatic activity of 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase is enhanced by NPM-ALK: new insights in ALK-mediated pathogenesis and the treatment of ALCL.
Boccalatte FE; Voena C; Riganti C; Bosia A; D'Amico L; Riera L; Cheng M; Ruggeri B; Jensen ON; Goss VL; Lee K; Nardone J; Rush J; Polakiewicz RD; Comb MJ; Chiarle R; Inghirami G
Blood; 2009 Mar; 113(12):2776-90. PubMed ID: 18845790
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia drives the assembly of the multienzyme purinosome complex.
Doigneaux C; Pedley AM; Mistry IN; Papayova M; Benkovic SJ; Tavassoli A
J Biol Chem; 2020 Jul; 295(28):9551-9566. PubMed ID: 32439803
[TBL] [Abstract][Full Text] [Related]
17. Human 5-aminoimidazole-4-carboxamide ribonucleotide transformylase/inosine 5'-monophosphate cyclohydrolase. A bifunctional protein requiring dimerization for transformylase activity but not for cyclohydrolase activity.
Vergis JM; Bulock KG; Fleming KG; Beardsley GP
J Biol Chem; 2001 Mar; 276(11):7727-33. PubMed ID: 11096114
[TBL] [Abstract][Full Text] [Related]
18. Loss of AIM2 expression promotes hepatocarcinoma progression through activation of mTOR-S6K1 pathway.
Ma X; Guo P; Qiu Y; Mu K; Zhu L; Zhao W; Li T; Han L
Oncotarget; 2016 Jun; 7(24):36185-36197. PubMed ID: 27167192
[TBL] [Abstract][Full Text] [Related]
19. MYO18B promotes hepatocellular carcinoma progression by activating PI3K/AKT/mTOR signaling pathway.
Zhang Z; Zhu J; Huang Y; Li W; Cheng H
Diagn Pathol; 2018 Nov; 13(1):85. PubMed ID: 30390677
[TBL] [Abstract][Full Text] [Related]
20. Inv(2)(p23q35) in anaplastic large-cell lymphoma induces constitutive anaplastic lymphoma kinase (ALK) tyrosine kinase activation by fusion to ATIC, an enzyme involved in purine nucleotide biosynthesis.
Ma Z; Cools J; Marynen P; Cui X; Siebert R; Gesk S; Schlegelberger B; Peeters B; De Wolf-Peeters C; Wlodarska I; Morris SW
Blood; 2000 Mar; 95(6):2144-9. PubMed ID: 10706887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
